Obesity (especially visceral adiposity) can be associated with 3 different phenotypes of heart
failure: heart failure with a reduced ejection fraction, heart failure with a preserved ejection …

Adipose tissue is no longer regarded as a non-secretory, inert, depot storage tissue, that
only serves the purposes of insulating the body from cold and/or merely storing energy that …

The concentration of adiponectin, a hormone which is secreted from adipose tissue, is
inversely correlated with body fat mass. This hormone has anti inflammatory and anti …

Dilated cardiomyopathy (DCM) is an important cause of sudden death and heart failure with
an unknown etiology. Recent studies have suggested that long non-coding RNA (lncRNA) …

Adiponectin is a cytokine produced by adipocytes and acts as a potential cardioprotective
agent and plays an important role in myocardial ischemia/reperfusion injury. In a myocardial …

Diabetes is a major health problem associated with adverse cardiovascular outcomes. The
apolipoprotein A‐I mimetic peptide L‐4F is a putative anti‐diabetic drug, has antioxidant and …

Objective Chemerin is a recently identified adipocytokine that has been positively correlated
with the presence and severity of coronary artery disease (CAD). However, no studies have …

Type 2 diabetes mellitus (DM) is associated with cognitive dysfunction and hippocampus
volume. The aim of the present study was to test the hypothesis that the level of the …

Heart failure (HF) is a major public health problem and the approach for an accurate
individualization of HF risk and care should include a profile of laboratory data, in addition to …

OBJECTIVE: Adiponectin (APN) improves insulin resistance and prevents atherosclerosis,
and HDL removes cholesterol from atherosclerotic lesions. We have demonstrated that …